Browse all Canadian datasets
Browse the complete CanQuery catalogue, including downloadable files, live tables and maps.
Open datasets
- Guidance Document - Guide for the Preparation of Applications for Authorization of Positron-emitting Radiopharmaceuticals for Use in Basic Clinical Research Studies
- COVID-19 treatments
- What we heard: Agile regulations for advanced therapeutic products and clinical trials
- Regulatory innovation for health products: Agile licensing for medical devices
- Regulatory innovation for health products: Information to Canadians – mobile strategy
- Regulatory innovation for health products: Overview
- Regulatory innovation for health products: Modernizing clinical trial regulations
- Regulatory innovation for health products: Enabling advanced therapeutic products
- Regulatory innovation for health products: Agile licensing for drugs
- Vaccines and treatments for COVID-19: Progress
- Vaccine development and approval in Canada
- House Committee on National Defence: Minister of National Defence Mandate Letter and Priorities (Appearance by the Minister of National Defence), 09 February, 2022
- Clinical trials and drug safety
- Medical devices for COVID-19: Conducting a clinical trial
- Conducting a clinical trial for COVID-19 medical devices: List of authorized clinical trials
- Regulatory roadmap for radiopharmaceutical (Schedule C) drugs in Canada
- Health Canada’s regulatory response to COVID-19: International engagement
- Health Canada’s regulatory response to COVID-19: Access to health products
- Classification of observations made in the conduct of inspections of clinical trials (GUIDE-0043)
- Clinical Trial Applications - process
- Instructions for completing the Clinical Trial Site Information Form
- Notice to Stakeholders: Statement on the Investigational Use of Marketed Drugs in Clinical Trials
- Clinical trials drug importation Frequently Asked Questions
- Clinical trials multiple subjects Frequently Asked Questions
- Clinical Trials Manual
- Clinical trials outline of process Frequently Asked Questions
- Filing of clinical trials Frequently Asked Questions
- Consultation on “Drugs for Clinical Trials Involving Human Subjects” (GUI-0100: Guidance Document – Part C, Division 5 of the Food and Drug Regulations)
- Good clinical practices: Guidance documents
- Good manufacturing practices and COVID-19
- Frequently Asked Questions - Common Electronic Submissions Gateway
- Welland Trees
- 2022-06-06 Recommendations-Recommendattions
- 2022-06-06 Agenda-Ordre du Jour (Media)
- National Action Plan on Open Government 2016-2018
- Mandate Letter Tracker
- 179 Centennial
- 2022-06-06 Agenda-Ordre du jour
- List of Broadcasting Distribution Undertakings
- Main & Lorentz Rezoning
- Decisions May 25 mai
- Census 2021 CD CCS Agriculture
- 2020 Poverty Expenditures Fredericton Neighbourhoods Map
- 2020 Income Fredericton Neighbourhoods Map
- DO Application
- Hydroelectric System
- 2016 Census Ward Boundary 2018 2022
- 2022-05-24 Agenda COTW
- Media Package PAC May 25
- Health Canada - Special Committee on the COVID-19 Pandemic - Deputy Head Briefing Binder - Emergency Meeting - HC - Special Committee on the COVID-19 Pandemic (COVI) - Deputy head Briefing Binder - Emergency Meeting